Articles
Volume 8 Supplement 1
Coartem®: reviewing the impact on the malaria landscape
Reviews
Edited by Marcel Hommel
Publication of this supplement has been sponsored by Novartis Pharma AG.
|
Malaria management - progress made and challenges still to face Bernhards R Ogutu Malaria Journal 2009, 8(Suppl 1):S1 (12 October 2009) |
|
Ongoing challenges in the management of malaria Gilbert Kokwaro Malaria Journal 2009, 8(Suppl 1):S2 (12 October 2009) |
|
Coartem®: the journey to the clinic Zulfiqarali G Premji Malaria Journal 2009, 8(Suppl 1):S3 (12 October 2009) |
|
Understanding the pharmacokinetics of Coartem® Abdoulaye Djimdé, Gilbert Lefèvre Malaria Journal 2009, 8(Suppl 1):S4 (12 October 2009) |
|
The clinical efficacy of artemether/lumefantrine (Coartem®) Michael Makanga, Srivicha Krudsood Malaria Journal 2009, 8(Suppl 1):S5 (12 October 2009) |
|
Safety profile of Coartem®: the evidence base Catherine Falade, Christine Manyando Malaria Journal 2009, 8(Suppl 1):S6 (12 October 2009) |
|
Salim Abdulla, Issaka Sagara Malaria Journal 2009, 8(Suppl 1):S7 (12 October 2009) |
|
Karen I Barnes, Pascalina Chanda, Gebre Ab Barnabas Malaria Journal 2009, 8(Suppl 1):S8 (12 October 2009) |

